Floatz logo

Ferumoxytol

Pancreatic Cancer

Massachusetts General HospitalOtherPhase 4 / ApprovedDormant
CCC
54/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
51/ 100
Competitive Position
59/ 100

Competitive context

373 Active assets in the Pancreatic Cancer cohort.

Asset / SponsorPhaseRating
Calcium folinate pentahydrate
Memorial Sloan Kettering Cancer Center
Phase 3BB
Eloxatin
Memorial Sloan Kettering Cancer Center
Phase 3BB
FLUOROURACILUM
Memorial Sloan Kettering Cancer Center
Phase 3BB
CIS-DIAMMINEDICHLOROPLATINUM II
Taiho Oncology, Inc.
Phase 3BB
Irinotecan
Memorial Sloan Kettering Cancer Center
Phase 3BB

View all 50 →

Same molecule, other indications

Ferumoxytol is also rated in:

cerebral atherosclerosisDormant
BB
Indicative ·
69 / 100
View asset →
glioblastomaDormant
B
Indicative ·
60 / 100
View asset →
multiple sclerosisDormant
B
Indicative ·
58 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →